NEW YORK (360Dx) – An assay from BioMérieux to detect acute kidney injury (AKI) has been shown in preliminary research to detect injury caused by sepsis earlier than the current standard of care. Integrating the NephroCheck AKI test and a procalcitonin test may potentially enable physicians to alter treatment before irreparable kidney damage occurs.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.